Wellington Management Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $150M | Buy |
|
|||||
|
2025
Q2 | $106M | Sell |
|
|||||
|
2025
Q1 | $152M | Sell |
|
|||||
|
2024
Q4 | $227M | Sell |
|
|||||
|
2024
Q3 | $314M | Buy |
|
|||||
|
2024
Q2 | $299M | Buy |
|
|||||
|
2024
Q1 | $321M | Buy |
|
|||||
|
2023
Q4 | $257M | Buy |
|
|||||
|
2023
Q3 | $149M | Buy |
|
|||||
|
2023
Q2 | $174M | Buy |
|
|||||
|
2023
Q1 | $150M | Sell |
|
|||||
|
2022
Q4 | $207M | Buy |
|
|||||
|
2022
Q3 | $86.6M | Buy |
|
|||||
|
2022
Q2 | $76.6M | Sell |
|
|||||
|
2022
Q1 | $120M | Buy |
|
|||||
|
2021
Q4 | $84.5M | Buy |
|
|||||
|
2021
Q3 | $118M | Buy |
|
|||||
|
2021
Q2 | $65.6M | Buy |
|
|||||
|
2021
Q1 | $38.9M | Buy |
|
|||||
|
2020
Q4 | $1.65M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $177K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $25.3M | Buy |
|